Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention.

Ji ZG, Liu HB, Liu ZH, Ma GP, Qin LQ, Dong W, Wang LY.

Chronic Dis Transl Med. 2015 Jul 6;1(2):81-88. doi: 10.1016/j.cdtm.2015.06.003. eCollection 2015 Jun.

2.
3.

Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.

Gwag HB, Kim EK, Park TK, Lee JM, Yang JH, Song YB, Choi JH, Choi SH, Lee SH, Chang SA, Park SJ, Lee SC, Park SW, Jang WJ, Lee M, Chun WJ, Oh JH, Park YH, Choe YH, Gwon HC, Hahn JY.

J Am Heart Assoc. 2017 Apr 3;6(4). pii: e005426. doi: 10.1161/JAHA.116.005426.

5.

Protective approaches against myocardial ischemia reperfusion injury.

Li X, Liu M, Sun R, Zeng Y, Chen S, Zhang P.

Exp Ther Med. 2016 Dec;12(6):3823-3829. doi: 10.3892/etm.2016.3877. Epub 2016 Nov 7.

6.
7.

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.

Gupta S, Gupta MM.

Indian Heart J. 2016 Jul-Aug;68(4):539-51. doi: 10.1016/j.ihj.2016.04.006. Epub 2016 Apr 19. Review.

8.

Effect of Thrombus Composition and Viscosity on Sonoreperfusion Efficacy in a Model of Micro-Vascular Obstruction.

Black JJ, Yu FT, Schnatz RG, Chen X, Villanueva FS, Pacella JJ.

Ultrasound Med Biol. 2016 Sep;42(9):2220-31. doi: 10.1016/j.ultrasmedbio.2016.04.004. Epub 2016 May 17.

9.

Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint.

Engblom H, Heiberg E, Erlinge D, Jensen SE, Nordrehaug JE, Dubois-Randé JL, Halvorsen S, Hoffmann P, Koul S, Carlsson M, Atar D, Arheden H.

J Am Heart Assoc. 2016 Mar 9;5(3):e002708. doi: 10.1161/JAHA.115.002708.

10.

QRS complex distortion (Grade 3 ischaemia) as a predictor of myocardial damage assessed by cardiac magnetic resonance imaging and clinical prognosis in patients with ST-elevation myocardial infarction.

Rommel KP, Badarnih H, Desch S, Gutberlet M, Schuler G, Thiele H, Eitel I.

Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):194-202. doi: 10.1093/ehjci/jev135. Epub 2015 Jun 9.

11.

The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Nazir SA, Khan JN, Mahmoud IZ, Greenwood JP, Blackman DJ, Kunadian V, Been M, Abrams KR, Wilcox R, Adgey AA, McCann GP, Gershlick AH.

Trials. 2014 Sep 25;15:371. doi: 10.1186/1745-6215-15-371.

12.

Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives.

Dziewierz A, Rakowski T, Dudek D.

Ther Clin Risk Manag. 2014 Jul 18;10:567-76. doi: 10.2147/TCRM.S50002. eCollection 2014. Review.

13.

Coronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and management.

Vecchio S, Varani E, Chechi T, Balducelli M, Vecchi G, Aquilina M, Ricci Lucchi G, Dal Monte A, Margheri M.

World J Cardiol. 2014 Jun 26;6(6):381-92. doi: 10.4330/wjc.v6.i6.381. Review.

14.

S-nitrosylation of TRIM72 mends the broken heart: a molecular modifier-mediated cardioprotection.

X'avia Chan CY, Wang D, Cadeiras M, Deng MC, Ping P.

J Mol Cell Cardiol. 2014 Jul;72:292-5. doi: 10.1016/j.yjmcc.2014.04.004. Epub 2014 Apr 13. No abstract available.

15.
16.

Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction.

Hong MK.

Scientifica (Cairo). 2012;2012:683683. doi: 10.6064/2012/683683. Epub 2012 Sep 16. Review.

17.

Intracoronary Reopro during Percutaneous Coronary Intervention in Acute and Stable Patient can Influence Stent Thrombosis Formation (IRPASST) Study.

Balghith M, Al-Ghamdi A, Zain el H, Al-Saileek A.

Heart Views. 2013 Apr;14(2):62-7. doi: 10.4103/1995-705X.115498.

18.

Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial.

de Waha S, Eitel I, Desch S, Scheller B, Böhm M, Lauer B, Gawaz M, Geisler T, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Zeymer U, Thiele H.

Trials. 2013 Apr 25;14:110. doi: 10.1186/1745-6215-14-110.

19.

Intracoronary versus intravenous administration of abciximab in patients with acute coronary syndrome: a meta-analysis.

Wang JN, Diao S, Tang YJ, Hou AJ, Yuan HB, Zheng Y, Zhou YH.

PLoS One. 2013;8(2):e58077. doi: 10.1371/journal.pone.0058077. Epub 2013 Feb 28.

20.

CMR of microvascular obstruction and hemorrhage in myocardial infarction.

Wu KC.

J Cardiovasc Magn Reson. 2012 Sep 29;14:68. doi: 10.1186/1532-429X-14-68. Review.

Supplemental Content

Support Center